相关实验视频
Updated: Jul 17, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.3K
慢性病中的心脏标志物和心血管疾病
Ying-Ju Chen1, Chih-Chieh Chen2, Tze-Kiong Er3
1Division of Laboratory Medicine, Asia University Hospital, Asia University, Taichung, Taiwan.
Advances in clinical chemistry
|September 6, 2023
概括
心血管疾病 (CVD) 在慢性病 (CKD) 患者中很常见. 识别心脏生物标志物可以改善风险评估和血液透析患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 生物标志物发现发现
背景情况:
- 心血管疾病 (CVD) 是慢性病 (CKD) 患者死亡的主要原因.
- 主要不良心血管事件是血液透析患者的主要死亡原因.
- 在CKD患者中,准确的心血管疾病风险分层对于改善临床结果至关重要.
研究的目的:
- 审查心脏生物标志物在评估CKD患者心血管风险中的作用.
- 探索心脏生物标志物对CKD心血管疾病结局的临床影响.
- 了解心脏生物标志物与CKD治疗策略之间的关系.
主要方法:
- 文献综述侧重于心血管生物标志物和CKD.
- 对报告CKD生物标志物的预后价值的研究分析.
- 综合目前对生物标志物在心血管疾病风险分层中的有用性的理解.
主要成果:
- 许多心脏生物标志物在CKD中显示了对心血管疾病不良结果的预后价值.
- 生物标志物可以帮助识别需要更密切监测和干预的高风险患者.
- 了解生物标志物的影响是完善预防和治疗策略的关键.
结论:
- 心脏生物标志物是控制CKD患者心血管疾病风险的重要工具.
- 通过生物标志物提高诊断准确度和风险识别,可以改善患者的治疗结果.
- 对于与CKD相关的CVD,需要对生物标志物引导的治疗策略进行进一步的研究.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
29
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
29
Chronic Kidney Disease IV: Nursing Management
25
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
25
Chronic Kidney Disease I: Introduction
34
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
34
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
201
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201

